Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases

Details for Australian Patent Application No. 2003301817 (hide)

Owner Cephalon, Inc.

Inventors McIntyre, Bradley T.; Patel, Piyush R.; Parikh, Alpa; Jacobs, Martin J.

Agent Watermark

Pub. Number AU-B-2003301817

PCT Number PCT/US2003/0340

PCT Pub. Number WO2004/041245

Priority 10/286,573 01.11.02 US

Filing date 24 October 2003

Wipo publication date 7 June 2004

Acceptance publication date 20 November 2008

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

24 June 2004 Complete Application Filed

  Priority application(s): 10/286,573 01.11.02 US

1 July 2004 Application Open to Public Inspection

  Published as AU-B-2003301817

20 November 2008 Application Accepted

  Published as AU-B-2003301817

19 March 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003301818-METHOD AND DEVICE FOR APPLYING FILTER INFORMATION TO IDENTIFY COMBINATIONS OF ELECTRODES

2003301816-SYSTEM FOR SUPPORTING A BODY USING OSSEO-PERCUTANEOUS IMPLANTS